Glucocerebrosidase (GBA) is a lysosomal enzyme that results in Gaucher's disease when deficient due to mutations.
Is it true that Glucocerebrosidase (GBA) is a lysosomal enzyme that results in Gaucher's disease when deficient due to mutations?
Yes. Glucocerebrosidase is a lysosomal enzyme encoded by the GBA1 gene, and deficiencies caused by mutations in this gene result in Gaucher disease.
Verdict: SUPPORTED · 9 sources for, 0 against · Last checked
The retrieved papers consistently confirm that mutations in the GBA/GBA1 gene lead to a deficiency in the lysosomal enzyme glucocerebrosidase, which causes Gaucher disease. There are no papers contradicting this established genetic and biochemical fact.
Get citation
A, K., T, C., E, S., & TU, H. (2024). Advancements in Viral Gene Therapy for Gaucher Disease.. doi.org. https://doi.org/10.3390/genes15030364
See more details
Get citation
F, C. & MG, B. (2025). Gaucher disease, state of the art and perspectives.. doi.org. https://doi.org/10.1111/joim.20114
Get citation
F, C., CJ, M., B, L., T, D., JM, J., M, C., C, C., K, K., G, T., E, C., E, S., E, S., S, S., IM, Y., J, P., J, K., N, N., P, K., S, C., Y, S., AP, D., R, S., AC, N., & R, C. (2025). FLT201, a novel liver-directed AAV gene therapy candidate for Gaucher disease type 1.. doi.org. https://doi.org/10.1016/j.ymthe.2025.05.003
Get citation
R, W., T, H., N, H., & D, C. (2026). Interplay of GBA1 with lysosomal dysfunction and inflammation in Parkinson's disease.. doi.org. https://doi.org/10.4103/nrr.nrr-d-25-01082
Get citation
Önal, G., Gümüş, E., Demir, H., Yüce, A., & (Emre), S. D. (2020). Molecular genetic analysis of Turkish Gaucher's disease patients reveals three novel variants in Glucocerebrosidase (GBA) gene. doi.org. https://doi.org/10.1016/j.mgene.2020.100725
Get citation
F, C., S, L., & M, S. (2026). Glucosylsphingosine (Lyso-Gb1): An Update on Its Use as a Biomarker in Gaucher Disease.. doi.org. https://doi.org/10.3390/ijms27041705
Get citation
DG, P., G, P., T, D., S, S., SM, J., & P, J. (2025). Genotype Meets Phenotype: Unraveling Gaucher's Genetic Landscape in the Indian Population.. doi.org. https://doi.org/10.7759/cureus.92009
Get citation
A, C., O, M., & G, C. (2026). Gaucher disease: the hematologist's perspective of a multisystemic disorder.. doi.org. https://doi.org/10.1007/s00277-026-06977-3
Get citation
V, F., G, D. R., V, F., A, C., F, C., & V, S. (2026). The dual impact of GBA1 in disease: from germline mutations in neurological disorders to alterations in cancer.. doi.org. https://doi.org/10.1038/s41420-026-03046-6
What does the evidence say?
The retrieved papers consistently confirm that mutations in the GBA/GBA1 gene lead to a deficiency in the lysosomal enzyme glucocerebrosidase, which causes Gaucher disease. There are no papers contradicting this established genetic and biochemical fact.
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work